AU540079B2 - Feline leukemia vaccine - Google Patents

Feline leukemia vaccine

Info

Publication number
AU540079B2
AU540079B2 AU65427/80A AU6542780A AU540079B2 AU 540079 B2 AU540079 B2 AU 540079B2 AU 65427/80 A AU65427/80 A AU 65427/80A AU 6542780 A AU6542780 A AU 6542780A AU 540079 B2 AU540079 B2 AU 540079B2
Authority
AU
Australia
Prior art keywords
feline leukemia
leukemia vaccine
vaccine
feline
leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU65427/80A
Other languages
English (en)
Other versions
AU6542780A (en
Inventor
Richard G. Olsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University Research Foundation
Original Assignee
Ohio State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22302393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU540079(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ohio State University Research Foundation filed Critical Ohio State University Research Foundation
Publication of AU6542780A publication Critical patent/AU6542780A/en
Application granted granted Critical
Publication of AU540079B2 publication Critical patent/AU540079B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU65427/80A 1979-12-18 1980-12-16 Feline leukemia vaccine Expired AU540079B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US104789 1979-12-18
US06/104,789 US4332793A (en) 1979-12-18 1979-12-18 Method of recovering cell antigen and preparation of feline leukemia vaccine therefrom

Publications (2)

Publication Number Publication Date
AU6542780A AU6542780A (en) 1981-06-25
AU540079B2 true AU540079B2 (en) 1984-11-01

Family

ID=22302393

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65427/80A Expired AU540079B2 (en) 1979-12-18 1980-12-16 Feline leukemia vaccine

Country Status (10)

Country Link
US (1) US4332793A (en:Method)
EP (1) EP0030728B1 (en:Method)
JP (1) JPS56127318A (en:Method)
AU (1) AU540079B2 (en:Method)
CA (1) CA1174168A (en:Method)
DE (1) DE3064338D1 (en:Method)
ES (1) ES497839A0 (en:Method)
IE (1) IE51007B1 (en:Method)
NZ (1) NZ195836A (en:Method)
ZA (1) ZA807876B (en:Method)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4701416A (en) * 1983-12-09 1987-10-20 Cetus Corporation Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
US5152982A (en) * 1984-03-26 1992-10-06 Chiron Corporation Compositions and methods for FeLV vaccination
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4789702A (en) * 1984-05-18 1988-12-06 Cetus Corporation Feline leukemia virus vaccine
US4876089A (en) * 1984-09-06 1989-10-24 Chiron Corporation Feline leukemia virus protein vaccines
US5352449A (en) * 1986-05-30 1994-10-04 Cambridge Biotech Corporation Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant
US5306493A (en) * 1986-10-03 1994-04-26 Miles Inc. FeLV-infected feline cell line
US5374424A (en) * 1986-10-03 1994-12-20 Miles Inc. Multivalent felv-infected feline vaccine
WO1990002567A1 (en) * 1988-09-02 1990-03-22 The Ohio State University Research Foundation Virus-derived antigenic composition and its preparation and use
IE74875B1 (en) * 1988-12-13 1997-08-13 Harvard College Prototype FeLV isolates for use in disease models and vaccines
WO1993004698A1 (en) * 1991-08-29 1993-03-18 Smithkline Beecham Corporation Method of enhancing anti-rabies immune responses
CA2127466A1 (en) * 1992-01-06 1993-07-22 Keith Haffer Feline leukemia virus vaccines
US7613958B2 (en) 2004-01-12 2009-11-03 Hewlett-Packard Development Company, L.P. Error detection in a system having coupled channels
US7721159B2 (en) * 2005-02-11 2010-05-18 Hewlett-Packard Development Company, L.P. Passing debug information
US7624213B2 (en) * 2005-02-11 2009-11-24 Hewlett-Packard Development Company, L.P. Passing identification information

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
GB1486186A (en) * 1973-09-18 1977-09-21 Univ Glasgow Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
US4406885A (en) * 1978-12-28 1983-09-27 Research Corporation Preparation of native oncornavirus envelope subunits and vaccines therefrom

Also Published As

Publication number Publication date
NZ195836A (en) 1984-02-03
ES8200816A1 (es) 1981-11-16
ES497839A0 (es) 1981-11-16
DE3064338D1 (en) 1983-08-25
CA1174168A (en) 1984-09-11
EP0030728A3 (en) 1981-12-23
EP0030728A2 (en) 1981-06-24
JPH0559096B2 (en:Method) 1993-08-30
IE802594L (en) 1981-06-18
ZA807876B (en) 1981-09-30
EP0030728B1 (en) 1983-07-20
US4332793A (en) 1982-06-01
AU6542780A (en) 1981-06-25
JPS56127318A (en) 1981-10-06
IE51007B1 (en) 1986-09-03

Similar Documents

Publication Publication Date Title
AU2489984A (en) Arylsulphonyls
AU6442980A (en) Azolyloxy-carboxylic acid -oxy-amides
AU540079B2 (en) Feline leukemia vaccine
AU5577580A (en) Breathalyser
AU525431B2 (en) Emulsans
AU527992B2 (en) 9-aminoalkylfluorenes
AU528665B2 (en) Breathalyser
AU532763B2 (en) 8-aminoalkyl-4-alkylpsoralens
AU533807B2 (en) Pyridothienotriazines
AU531808B2 (en) Tetrahydrobenzothiazolylimidazolidinones
AU6133880A (en) N-cyanoimidate
AU5833980A (en) Thiazolylidene-oxo-propionitriles
AU6211680A (en) 2-amino-3-benzoyl-phenylacetamides
AU536556B2 (en) Aldehyde-ethers
AU6495080A (en) Delta-quinoline derivateves
AU528075B2 (en) Z-aza-ergolines
AU538686B2 (en) 1-substituted-2-pyrrolidinones
AU535376B2 (en) N-oximinoalkyl-anilides
AU534329B2 (en) Guanioinothiazoles
AU6562880A (en) O-alkyl-s-branched alkyl-alkylphosphonodithicates
AU528077B2 (en) Indexing
AU3302184A (en) Woolpack
AU4319879A (en) Boat-carrier
AU5975580A (en) Phthalimidinopentane defleecing
AU534625B2 (en) Clostridal vaccine

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired